UnicoCell Biomed Co (TPE:6794) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:6794 UnicoCell Biomed Co Ltd TPE:6794
80 GF Score
Price NT$71.80
GF Value NT$64.94
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is UnicoCell Biomed Co Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

TPE:6794 vs VRTX, REGN, RVMD: Short Interest Comparison

For the Biotechnology subindustry, UnicoCell Biomed Co's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

UnicoCell Biomed Co Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, UnicoCell Biomed Co's Short Interest distribution charts can be found below:

* The bar in red indicates where UnicoCell Biomed Co's Short Interest falls into.


TPE:6794
80GF Score
UnicoCell Biomed Co Ltd TPE:6794
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is UnicoCell Biomed Co (TPE:6794) Overvalued in 2026?

Based on GuruFocus' analysis, UnicoCell Biomed Co stock appears to be overvalued. The current stock price of NT$71.80 is trading 10.6% above its estimated GF Value™ of NT$64.94. GuruFocus considers UnicoCell Biomed Co to be Modestly Overvalued.

Key valuation signals for TPE:6794:

  • Short Interest:
  • GF Value™: NT$64.94 vs. price of NT$71.80 (10.6% above fair value)
  • GF Score™: 80/100 with 2 warning signs

No single metric tells the full story. See the TPE:6794 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

UnicoCell Biomed Co Business Description

Address Minquan East Road, 5th Floor, No. 13-20, Section 6, Neihu District, Taipei, TWN, 11494
UnicoCell Biomed Co Ltd is engaged in new drug R&D and human tissue-derived stem cell inspection and testing, extraction, storage, and technology R&D. It focuses on researching and developing stem cells and its derived technology for medical applications, with the goal of advancing human health and improving quality of life. The company's products include Allogeneic Adipose Stem Cell Bank, Autologous Stem Cell Therapy, Conditioned Medium, Mass Production and CDMO, Cryogenic Vial (Class 2 Medical Device), and Testing services. It operates in single segment. Geographically, its operations are spread across Taiwan, Japan and Others with Taiwan generating the majority of the revenue.
80GF Score

Get the complete analysis for TPE:6794

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$71.80
Price
NT$64.94
GF Value